Are you a new member? Sign up now
Login area
| Sign up
close
DASATINIB NEAPOLIS - 50mg - 60
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01EA02 | G | Dasatinib - 50mg | 10965/388 | 722/1 | DASATINIB NEAPOLIS | 50mg | 60 | Tablet, film coated | Oral | Medis Pharm Drugstore | Neapolis Pharma | Tunisia | L.L | 2.44 | E2 | Neapolis Pharma | Tunisia | 2/5/2024 |
Drugs With Same Ingredients
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01EA02 | B | Dasatinib - 50mg | 4018 | 24535/07 | SPRYCEL | 50mg | 60 | Tablet | Oral | Pacific pharma | AstraZeneca Pharmaceuticals LP, Indiana | USA | 212,274,841 L.L | 2.44 | E2 | 2/5/2024 | 0 | ||
| L01EA02 | G | Dasatinib - 50mg | 11104 | 21421/1 | APO-DASATINIB | 50mg | 30 | Tablet | Oral | Promopharm S.A.R.L. | Apotex Inc | Canada | 127,980,016 L.L | 2.44 | E2 | Apotex Inc | Canada | 2/5/2024 | 0 |
| L01EA02 | G | Dasatinib - 50mg | 11132 | 114120/1 | DALEUBIN | 50mg | 60 | Tablet, film coated | Oral | Khalil Fattal & Fils S.A.L. | Lek Pharmaceuticals dd | Slovenia | 94,817,102 L.L | 2.44 | E2 | 1A Pharma GmbH | Germany | 2/5/2024 | 0 |
| L01EA02 | G | Dasatinib - 50mg | 10965 | 722/1 | DASATINIB NEAPOLIS | 50mg | 60 | Tablet, film coated | Oral | Medis Pharm Drugstore | Neapolis Pharma | Tunisia | 219,541,889 L.L | 2.44 | E2 | Neapolis Pharma | Tunisia | 2/5/2024 | 0 |
| L01EA02 | G | Dasatinib - 50mg | 11005 | 219/1 | ELPIDA | 50mg | 60 | Tablet, film coated | Oral | Droguerie Mercury S.A.L. | The Arab Pharmaceutical Manufacturing PSC | Jordan | 219,541,889 L.L | 2.44 | E2 | Hikma Pharmaceuticals | Jordan | 2/5/2024 | 0 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024